Cost Implications of Early Treatment Initiation Among Patients With Newly Diagnosed Fibromyalgia.
- Resource Type
- Article
- Authors
- Frech, Feride; Chunlin Qian; Gore, Mugdha; Qiaoyi Zhang
- Source
- American Journal of Pharmacy Benefits; Nov/Dec2017, Vol. 9 Issue 6, p1-3, 3p
- Subject
- ANTIDEPRESSANTS
THERAPEUTIC use of narcotics
TRANQUILIZING drugs
SEROTONIN uptake inhibitors
MUSCLE relaxants
MEDICAL care costs
EARLY medical intervention
FIBROMYALGIA
ECONOMICS
DIAGNOSIS
THERAPEUTICS
- Language
- ISSN
- 19454481
The article discusses a study that focuses on the cost implications of early treatment initiation among patients with newly diagnosed fibromyalgia. The most commonly used other pain medications at baseline among all patients treated with a fibromyalgia-related medication were mentioned. Unadjusted baseline and follow-up healthcare costs by category for propensity matched groups are discussed. The impact of using a 90-day threshold instead of two months is analyzed.